Kiniksa Pharmaceuticals Ltd (KNSA)
20.33
+0.34
(+1.70%)
USD |
NASDAQ |
May 07, 16:00
20.33
0.00 (0.00%)
After-Hours: 20:00
Kiniksa Pharmaceuticals Price to Book Value: 3.339 for May 7, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 3.283 |
| May 03, 2024 | 3.298 |
| May 02, 2024 | 3.183 |
| May 01, 2024 | 3.186 |
| April 30, 2024 | 3.075 |
| April 29, 2024 | 3.047 |
| April 26, 2024 | 2.937 |
| April 25, 2024 | 2.892 |
| April 24, 2024 | 2.934 |
| April 23, 2024 | 2.904 |
| April 22, 2024 | 2.808 |
| April 19, 2024 | 2.778 |
| April 18, 2024 | 2.773 |
| April 17, 2024 | 2.784 |
| April 16, 2024 | 2.868 |
| April 15, 2024 | 2.864 |
| April 12, 2024 | 2.835 |
| April 11, 2024 | 2.902 |
| April 10, 2024 | 2.861 |
| April 09, 2024 | 2.907 |
| April 08, 2024 | 2.899 |
| April 05, 2024 | 2.935 |
| April 04, 2024 | 2.961 |
| April 03, 2024 | 2.991 |
| April 02, 2024 | 3.071 |
| Date | Value |
|---|---|
| April 01, 2024 | 3.230 |
| March 31, 2024 | |
| March 28, 2024 | 3.175 |
| March 27, 2024 | 3.217 |
| March 26, 2024 | 3.213 |
| March 25, 2024 | 3.212 |
| March 22, 2024 | 3.213 |
| March 21, 2024 | 3.186 |
| March 20, 2024 | 3.183 |
| March 19, 2024 | 3.17 |
| March 18, 2024 | 3.151 |
| March 15, 2024 | 3.217 |
| March 14, 2024 | 3.275 |
| March 13, 2024 | 3.292 |
| March 12, 2024 | 3.289 |
| March 11, 2024 | 3.273 |
| March 08, 2024 | 3.349 |
| March 07, 2024 | 3.421 |
| March 06, 2024 | 3.379 |
| March 05, 2024 | 3.247 |
| March 04, 2024 | 3.249 |
| March 01, 2024 | 3.498 |
| February 29, 2024 | 3.402 |
| February 28, 2024 | 3.276 |
| February 27, 2024 | 3.362 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.141
Minimum
Oct 18 2019
7.404
Maximum
Jun 29 2020
3.500
Average
3.374
Median
Sep 22 2021
Price to Book Value Benchmarks
| Amicus Therapeutics Inc | 19.23 |
| Geron Corp | 6.647 |
| United Therapeutics Corp | 2.214 |
| Vanda Pharmaceuticals Inc | 0.5771 |
| TG Therapeutics Inc | 1.738 |
Price to Book Value Related Metrics
| PE Ratio | 184.82 |
| PS Ratio | 4.889 |
| Price to Free Cash Flow | 69.06 |
| Price | 20.33 |
| Earnings Yield | 0.54% |
| Market Cap | 1.442B |
| Normalized PE Ratio | 184.82 |